17th Clinical Trials on Alzheimer’s Disease (CTAD)
…to introduce LucentAD Complete, a best-in-class, ultrasensitive, non-invasive blood test for patients being evaluated for Alzheimer’s Disease. Powered by Quanterix’s digital Simoa® technology, LucentAD Complete offers a simple blood draw approach to diagnostics…
read more